{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T02:14:59Z","timestamp":1787537699585,"version":"build-2736575974"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372842"],"award-info":[{"award-number":["82372842"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202911"],"award-info":[{"award-number":["82202911"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372843"],"award-info":[{"award-number":["82372843"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2025J01137"],"award-info":[{"award-number":["2025J01137"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["BX20250229"],"award-info":[{"award-number":["BX20250229"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2023AFB210"],"award-info":[{"award-number":["2023AFB210"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2024AFB640"],"award-info":[{"award-number":["2024AFB640"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["82300786"],"award-info":[{"award-number":["82300786"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.drup.2025.101332","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:26:35Z","timestamp":1764721595000},"page":"101332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["UBL3 governs VEGFR inhibitor resistance by activating NOTCH signaling in renal cell carcinoma"],"prefix":"10.1016","volume":"85","author":[{"given":"Diaoyi","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1033-2482","authenticated-orcid":false,"given":"Yuzhong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daojia","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanyi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junkai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanglin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyang","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinshuo","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4569-5597","authenticated-orcid":false,"given":"Hailong","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.drup.2025.101332_bib1","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.1038\/s41467-018-06197-y","article-title":"UBL3 modification influences protein sorting to small extracellular vesicles","volume":"9","author":"Ageta","year":"2018","journal-title":"Nat. Commun."},{"issue":"24","key":"10.1016\/j.drup.2025.101332_bib2","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.1007\/s00018-019-03246-7","article-title":"Post-translational modification and protein sorting to small extracellular vesicles including exosomes by ubiquitin and UBLs","volume":"76","author":"Ageta","year":"2019","journal-title":"Cell. Mol. life Sci."},{"issue":"7","key":"10.1016\/j.drup.2025.101332_bib3","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/mt.2010.85","article-title":"Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms","volume":"18","author":"Akinc","year":"2010","journal-title":"Molecular Ther. J. Am. Soc. Gene Ther."},{"issue":"4","key":"10.1016\/j.drup.2025.101332_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22041846","article-title":"Analysis of the conditions that affect the selective processing of endogenous Notch1 by ADAM10 and ADAM17","volume":"22","author":"Alabi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"19","key":"10.1016\/j.drup.2025.101332_bib5","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1158\/0008-5472.CAN-13-3724","article-title":"EGFR blockade enriches for lung cancer stem-like cells through Notch3-dependent signaling","volume":"74","author":"Arasada","year":"2014","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.drup.2025.101332_bib6","doi-asserted-by":"crossref","first-page":"E509","DOI":"10.1073\/pnas.1512952113","article-title":"Nicastrin functions to sterically hinder \u03b3-secretase-substrate interactions driven by substrate transmembrane domain","volume":"113","author":"Bolduc","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.drup.2025.101332_bib7","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1172\/JCI126896","article-title":"Notch inhibition overcomes resistance to tyrosine kinase inhibitors in EGFR-driven lung adenocarcinoma","volume":"130","author":"Bousquet Mur","year":"2020","journal-title":"J. Clin. Invest"},{"issue":"21","key":"10.1016\/j.drup.2025.101332_bib8","doi-asserted-by":"crossref","first-page":"5679","DOI":"10.1128\/MCB.00406-09","article-title":"Selective use of ADAM10 and ADAM17 in activation of Notch1 signaling","volume":"29","author":"Bozkulak","year":"2009","journal-title":"Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.drup.2025.101332_bib9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40880-019-0405-5","article-title":"Comparison of efficacy and safety among axitinib, sunitinib, and sorafenib as neoadjuvant therapy for renal cell carcinoma: a retrospective study","volume":"39","author":"Cai","year":"2019","journal-title":"Cancer Commun."},{"key":"10.1016\/j.drup.2025.101332_bib10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ctrv.2016.09.002","article-title":"Improvement in survival end points of patients with metastatic renal cell carcinoma through sequential targeted therapy","volume":"50","author":"Calvo","year":"2016","journal-title":"Cancer Treat. Rev."},{"issue":"1","key":"10.1016\/j.drup.2025.101332_bib11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12943-018-0886-x","article-title":"A new ALK isoform transported by extracellular vesicles confers drug resistance to melanoma cells","volume":"17","author":"Cesi","year":"2018","journal-title":"Mol. Cancer"},{"issue":"19","key":"10.1016\/j.drup.2025.101332_bib12","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1510016","article-title":"Cabozantinib versus Everolimus in advanced renal-cell carcinoma","volume":"373","author":"Choueiri","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.drup.2025.101332_bib13","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S1470-2045(16)30107-3","article-title":"Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial","volume":"17","author":"Choueiri","year":"2016","journal-title":"Lancet Oncol."},{"issue":"10","key":"10.1016\/j.drup.2025.101332_bib14","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1038\/s41591-020-1093-z","article-title":"Targeting the HIF2-VEGF axis in renal cell carcinoma","volume":"26","author":"Choueiri","year":"2020","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.drup.2025.101332_bib15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4161\/fly.18823","article-title":"The ADAM family: insights into notch proteolysis","volume":"6","author":"Christian","year":"2012","journal-title":"Fly"},{"issue":"7","key":"10.1016\/j.drup.2025.101332_bib16","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1110\/ps.072834007","article-title":"Solution structure of a membrane-anchored ubiquitin-fold (MUB) protein from Homo sapiens","volume":"16","author":"De La Cruz","year":"2007","journal-title":"Protein Sci. A Publ. Protein Soc."},{"issue":"37","key":"10.1016\/j.drup.2025.101332_bib17","doi-asserted-by":"crossref","first-page":"27145","DOI":"10.1074\/jbc.M602283200","article-title":"MUBs, a family of ubiquitin-fold proteins that are plasma membrane-anchored by prenylation","volume":"281","author":"Downes","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.drup.2025.101332_bib18","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJMoa2210140","article-title":"Nirogacestat, a \u03b3-Secretase inhibitor for Desmoid tumors","volume":"388","author":"Gounder","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.drup.2025.101332_bib19","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1128\/MCB.00206-14","article-title":"Regulated proteolysis of NOTCH2 and NOTCH3 receptors by ADAM10 and presenilins","volume":"34","author":"Groot","year":"2014","journal-title":"Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.drup.2025.101332_bib20","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1756-9966-32-26","article-title":"Inhibition of ADAM-17 more effectively down-regulates the Notch pathway than that of \u03b3-secretase in renal carcinoma","volume":"32","author":"Guo","year":"2013","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.drup.2025.101332_bib21","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","article-title":"Targeting PI3K\/Akt signal transduction for cancer therapy","volume":"6","author":"He","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"9","key":"10.1016\/j.drup.2025.101332_bib22","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/nbt.3290","article-title":"Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells","volume":"33","author":"Hendel","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"12","key":"10.1016\/j.drup.2025.101332_bib23","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.drup.2025.101332_bib24","article-title":"Renal cell carcinoma","volume":"3","author":"Hsieh","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"4","key":"10.1016\/j.drup.2025.101332_bib25","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s12276-022-00754-8","article-title":"\u03b3-Secretase in Alzheimer's disease","volume":"54","author":"Hur","year":"2022","journal-title":"Exp. Mol. Med."},{"issue":"8","key":"10.1016\/j.drup.2025.101332_bib26","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1200\/JCO.2013.50.3961","article-title":"Randomized phase III trial of temsirolimus versus sorafenib as second-line therapy after sunitinib in patients with metastatic renal cell carcinoma","volume":"32","author":"Hutson","year":"2014","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.drup.2025.101332_bib27","article-title":"Sunitinib resistance in renal cell carcinoma: from molecular mechanisms to predictive biomarkers","volume":"67","author":"Jin","year":"2023","journal-title":"Drug Resist. Update. Rev. Comment. Antimicrob. Anticancer Chemother."},{"issue":"4","key":"10.1016\/j.drup.2025.101332_bib28","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.1021\/acsnano.9b10033","article-title":"Endocytosis of extracellular vesicles and release of their cargo from endosomes","volume":"14","author":"Joshi","year":"2020","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.drup.2025.101332_bib29","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nprot.2017.016","article-title":"Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening","volume":"12","author":"Joung","year":"2017","journal-title":"Nat. Protoc."},{"issue":"6478","key":"10.1016\/j.drup.2025.101332_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.drup.2025.101332_bib31","article-title":"Molecular impact of NOTCH signaling dysregulation on ovarian cancer progression, chemoresistance, and taxane response","volume":"191","author":"Koucka","year":"2025","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"key":"10.1016\/j.drup.2025.101332_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202514566","article-title":"AP2M1 amplification orchestrates notch-mediated chemoresistance in hematopoietic stem cells of acute myeloid leukemia patients","author":"Lee","year":"2025","journal-title":"Adv. Science"},{"issue":"1","key":"10.1016\/j.drup.2025.101332_bib33","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12943-019-1077-0","article-title":"ASPH-notch Axis guided exosomal delivery of prometastatic secretome renders breast cancer multi-organ metastasis","volume":"18","author":"Lin","year":"2019","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.drup.2025.101332_bib34","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13046-023-02625-0","article-title":"HES1-mediated down-regulation of miR-138 sustains NOTCH1 activation and promotes proliferation and invasion in renal cell carcinoma","volume":"42","author":"Liu","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.drup.2025.101332_bib35","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1038\/s41467-022-29524-w","article-title":"Ubiquitin-like protein 3 (UBL3) is required for MARCH ubiquitination of major histocompatibility complex class II and CD86","volume":"13","author":"Liu","year":"2022","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.drup.2025.101332_bib36","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.eururo.2015.01.005","article-title":"EAU guidelines on renal cell carcinoma: 2014 update","volume":"67","author":"Ljungberg","year":"2015","journal-title":"Eur. Urol."},{"issue":"14","key":"10.1016\/j.drup.2025.101332_bib37","doi-asserted-by":"crossref","first-page":"8108","DOI":"10.1073\/pnas.95.14.8108","article-title":"The Notch1 receptor is cleaved constitutively by a furin-like convertase","volume":"95","author":"Logeat","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.drup.2025.101332_bib38","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ccr.2012.06.014","article-title":"Therapeutic effect of \u03b3-secretase inhibition in KrasG12V-driven non-small cell lung carcinoma by derepression of DUSP1 and inhibition of ERK","volume":"22","author":"Maraver","year":"2012","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.drup.2025.101332_bib39","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ejca.2013.08.021","article-title":"Sunitinib objective response in metastatic renal cell carcinoma: analysis of 1059 patients treated on clinical trials","volume":"50","author":"Molina","year":"2014","journal-title":"Eur. J. Cancer (Oxford England 1990)"},{"key":"10.1016\/j.drup.2025.101332_bib40","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v3.24641","article-title":"Routes and mechanisms of extracellular vesicle uptake","volume":"3","author":"Mulcahy","year":"2014","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.drup.2025.101332_bib41","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2147\/OTT.S56370","article-title":"Clinical impact of targeted therapies in patients with metastatic clear-cell renal cell carcinoma","volume":"7","author":"Nerich","year":"2014","journal-title":"Onco-Targ. Ther."},{"issue":"11","key":"10.1016\/j.drup.2025.101332_bib42","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1016\/j.cell.2021.04.038","article-title":"Single-cell protein activity analysis identifies recurrence-associated renal tumor macrophages","volume":"184","author":"Obradovic","year":"2021","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.drup.2025.101332_bib43","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/nm1636","article-title":"Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia","volume":"13","author":"Palomero","year":"2007","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.drup.2025.101332_bib44","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1158\/0008-5472.CAN-21-3432","article-title":"Extracellular vesicle-mediated transfer of LncRNA IGFL2-AS1 confers Sunitinib resistance in renal cell carcinoma","volume":"83","author":"Pan","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2025.101332_bib45","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1146\/annurev-med-041916-124132","article-title":"Modern systemic therapy for metastatic renal cell carcinoma of the clear cell type","volume":"69","author":"Parikh","year":"2018","journal-title":"Annu. Rev. Med."},{"issue":"1","key":"10.1016\/j.drup.2025.101332_bib46","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1158\/1078-0432.CCR-22-1366","article-title":"Molecular mechanisms and future implications of VEGF\/VEGFR in cancer therapy","volume":"29","author":"Patel","year":"2023","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.drup.2025.101332_bib47","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.eururo.2015.02.001","article-title":"Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM registry","volume":"68","author":"Pierorazio","year":"2015","journal-title":"Eur. Urol."},{"issue":"2","key":"10.1016\/j.drup.2025.101332_bib48","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00401-020-02254-3","article-title":"Exosomes induce endolysosomal permeabilization as a gateway by which exosomal tau seeds escape into the cytosol","volume":"141","author":"Polanco","year":"2021","journal-title":"Acta Neuropathol."},{"issue":"2","key":"10.1016\/j.drup.2025.101332_bib49","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/sj.cdd.4400637","article-title":"Apoptotic response to growth factor deprivation involves cooperative interactions between c-Fos and p300","volume":"7","author":"Preston","year":"2000","journal-title":"Cell Death Differ."},{"issue":"6","key":"10.1016\/j.drup.2025.101332_bib50","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v26.i6.10","article-title":"Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic","volume":"26","author":"Puri","year":"2009","journal-title":"Crit. Rev. Ther. Drug Carr. Syst."},{"issue":"5","key":"10.1016\/j.drup.2025.101332_bib51","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.ccell.2016.03.004","article-title":"Exosome-transmitted lncARSR promotes Sunitinib resistance in renal cancer by acting as a competing endogenous RNA","volume":"29","author":"Qu","year":"2016","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.drup.2025.101332_bib52","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.ymthe.2023.02.013","article-title":"Exploiting the biogenesis of extracellular vesicles for bioengineering and therapeutic cargo loading","volume":"31","author":"R\u00e4dler","year":"2023","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"issue":"9807","key":"10.1016\/j.drup.2025.101332_bib53","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1016\/S0140-6736(11)61613-9","article-title":"Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial","volume":"378","author":"Rini","year":"2011","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.drup.2025.101332_bib54","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1182\/blood-2014-10-608448","article-title":"Therapeutic targeting of HES1 transcriptional programs in T-ALL","volume":"125","author":"Schnell","year":"2015","journal-title":"Blood"},{"issue":"6166","key":"10.1016\/j.drup.2025.101332_bib55","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1247005","article-title":"Genome-scale CRISPR-Cas9 knockout screening in human cells","volume":"343","author":"Shalem","year":"2014","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.drup.2025.101332_bib56","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41392-024-01828-x","article-title":"Notch signaling pathway in cancer: from mechanistic insights to targeted therapies","volume":"9","author":"Shi","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.drup.2025.101332_bib57","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA A Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.drup.2025.101332_bib58","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1111\/cas.15674","article-title":"Notch pathway regulates osimertinib drug-tolerant persistence in EGFR-mutated non-small-cell lung cancer","volume":"114","author":"Takahashi","year":"2023","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.drup.2025.101332_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1247\/csf.21078","article-title":"Ubiquitin-like 3 as a new protein-sorting factor for small extracellular vesicles","volume":"47","author":"Takanashi","year":"2022","journal-title":"Cell Struct. Funct."},{"issue":"32","key":"10.1016\/j.drup.2025.101332_bib60","doi-asserted-by":"crossref","first-page":"22258","DOI":"10.1074\/jbc.M114.588046","article-title":"Exosome uptake through clathrin-mediated endocytosis and macropinocytosis and mediating miR-21 delivery","volume":"289","author":"Tian","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.drup.2025.101332_bib61","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41587-020-0565-5","article-title":"The delivery challenge: fulfilling the promise of therapeutic genome editing","volume":"38","author":"Van Haasteren","year":"2020","journal-title":"Nat. Biotechnol."},{"issue":"45","key":"10.1016\/j.drup.2025.101332_bib62","doi-asserted-by":"crossref","first-page":"31018","DOI":"10.1074\/jbc.M109.006775","article-title":"Metalloprotease ADAM10 is required for Notch1 site 2 cleavage","volume":"284","author":"Van Tetering","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.drup.2025.101332_bib63","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/bjc.2013.119","article-title":"Treatment and overall survival in renal cell carcinoma: a Swedish population-based study (2000-2008)","volume":"108","author":"Wahlgren","year":"2013","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.drup.2025.101332_bib64","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41467-017-00767-2","article-title":"Plasma membrane-derived extracellular microvesicles mediate non-canonical intercellular NOTCH signaling","volume":"8","author":"Wang","year":"2017","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.drup.2025.101332_bib65","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41392-022-00890-7","article-title":"Elevated Kir2.1\/nuclear N2ICD defines a highly malignant subtype of non-WNT\/SHH medulloblastomas","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.drup.2025.101332_bib66","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13046-017-0507-3","article-title":"Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma","volume":"36","author":"Xiao","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"16","key":"10.1016\/j.drup.2025.101332_bib67","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1016\/j.ejca.2013.07.007","article-title":"Notch-1 contributes to epidermal growth factor receptor tyrosine kinase inhibitor acquired resistance in non-small cell lung cancer in vitro and in vivo","volume":"49","author":"Xie","year":"2013","journal-title":"European Journal Cancer (Oxford England 1990)"},{"issue":"1","key":"10.1016\/j.drup.2025.101332_bib68","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bbrc.2004.12.137","article-title":"The role of apolipoprotein E in the elimination of liposomes from blood by hepatocytes in the mouse","volume":"328","author":"Yan","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.drup.2025.101332_bib69","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1038\/s41467-023-38833-7","article-title":"NOTCH4(\u0394L12_16) sensitizes lung adenocarcinomas to EGFR-TKIs through transcriptional down-regulation of HES1","volume":"14","author":"Zhang","year":"2023","journal-title":"Nat. Commun."}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764625001359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764625001359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T17:07:03Z","timestamp":1778605623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764625001359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":69,"alternative-id":["S1368764625001359"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2025.101332","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"UBL3 governs VEGFR inhibitor resistance by activating NOTCH signaling in renal cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2025.101332","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101332"}}